First-in-Class, Potent and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis. Journal of Medicinal Chemistry (2010).

B. Laleu, F. Gaggini, M. Orchard, L. Fioraso-Cartier, L. Cagnon, S. Molango, A. Gradia, G. Duboux, C. Merlot, F. Heitz, C. Szyndralewiez, P. Page

Journal of Medicinal Chemistry, 2010, 53 (21), 7715-30

Link to the article